S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
U.S. Loses to China in Shocking WAR GAMES (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Avoid the upcoming bloodbath (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
U.S. Loses to China in Shocking WAR GAMES (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Avoid the upcoming bloodbath (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
U.S. Loses to China in Shocking WAR GAMES (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Avoid the upcoming bloodbath (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
U.S. Loses to China in Shocking WAR GAMES (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Avoid the upcoming bloodbath (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
NASDAQ:MITO

Stealth BioTherapeutics (MITO) Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.32
▼
$0.32
50-Day Range
$0.31
▼
$0.32
52-Week Range
$0.16
▼
$1.03
Volume
N/A
Average Volume
946,105 shs
Market Capitalization
$23.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50
ProfileAnalyst RatingsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MITO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MITO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Stealth BioTherapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.01)($0.01)($0.01)
Q2 20231($0.02)($0.02)($0.02)
Q3 20231($0.02)($0.02)($0.02)

Stealth BioTherapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/18/2022Q1 2022($0.02)($0.12)($0.10)($0.12)
4/7/2022Q4 2021($0.36)($0.36)($0.36)
11/11/2021Q3 2021($0.02)($0.02)($0.03)    
8/5/20216/30/2021($0.02)($0.03)($0.01)($0.03)  
5/18/2021Q1($0.02)($0.01)+$0.01($0.01)  
4/5/202112/31/2020$0.01($0.03)($0.04)($0.36)  
11/5/20209/30/2020($0.02)($0.02)($0.02)  
8/6/20206/30/2020($0.02)($0.02)($0.02)  
5/7/20203/31/2020($0.03)($0.04)($0.01)($0.04)  
4/1/2020Q4 2019($0.04)$0.12+$0.16$0.12$21.09 million
11/14/2019Q3($0.04)($0.04)($0.04)  
8/14/2019Q2($0.0780)($0.04)+$0.0380($0.04)
5/15/2019Q1 2019($0.26)($0.12)+$0.14($0.04)












Stealth BioTherapeutics Earnings - Frequently Asked Questions

How much revenue does Stealth BioTherapeutics generate each year?

Stealth BioTherapeutics (NASDAQ:MITO) has a recorded annual revenue of $21.09 million.

How much profit does Stealth BioTherapeutics generate each year?

Stealth BioTherapeutics (NASDAQ:MITO) has a recorded net income of -$52.53 million. MITO has generated -$0.52 earnings per share over the last four quarters.

What is Stealth BioTherapeutics's EPS forecast for next year?

Stealth BioTherapeutics's earnings are expected to grow from ($0.06) per share to ($0.05) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:MITO) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -